Accrol Group Holdings PLC Directorate Change (2209U)

TIDMACRL

RNS Number : 2209U

Accrol Group Holdings PLC

11 July 2018

11 July 2018

Accrol Group Holdings plc

("Accrol")

AIM: ACRL

DIRECTORATE CHANGE

Accrol, the leading independent tissue converter in the UK, announces that, following the appointment of Steve Townsley as Chief Financial Officer on 11 June 2018, Martin Leitch has now stepped down from the Board.

Martin was appointed to the Board as Interim CFO in February 2018 to assist in the early stages of the business turnaround and to allow a search for a permanent CFO to be conducted in an orderly fashion. He will remain with the business for a short period to complete an effective handover.

Dan Wright, Executive Chairman of Accrol, said: "On behalf of the Board, I extend our thanks to Martin for his considerable support and help in progressing the turnaround of the business."

Enquiries:

 
 Accrol Group Holdings plc                       Tel: [phone] 
                                                           278 844 
 Dan Wright, Executive Chairman 
 Gareth Jenkins, Chief Executive Officer 
 Steve Townsley, Chief Financial Officer 
 
 Zeus Capital Limited (Nominated Adviser 
  & Broker) 
 Dan Bate / Andrew Jones                      Tel: [phone] 
                                                              1512 
 Dominic King / John Goold                    Tel: [phone] 
                                                              5000 
 
 Belvedere Communications Limited             Tel: [phone] 
                                                              0510 
 Cat Valentine ([e-mail]) 
 Llewellyn Angus ([e-mail]) 
 

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.

Accrol operates from three sites:

   --      A manufacturing, storage and distribution facility in Blackburn; 
   --      A facial tissue plant, also in Blackburn; and 
   --      A manufacturing, storage and distribution facility in Leyland. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

BOABLGDRDGBBGIG

(END) Dow Jones Newswires

July 11, 2018 02:00 ET (06:00 GMT)